Technology
Health
Pharmaceutical

Cerecor

$5.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-1.43%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Cerecor and other stocks, options, ETFs, and crypto commission-free!

About

Cerecor Inc. Common Stock, also called Cerecor, is a clinical stage biopharmaceutical company focuses in medical development. Read More It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.

Employees
64
Headquarters
Rockville, Maryland
Founded
2011
Market Cap
228.10M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
102.70K
High Today
$5.60
Low Today
$5.25
Open Price
$5.60
Volume
81.62K
52 Week High
$7.65
52 Week Low
$2.71

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2015 IPO
US
North America

News

Seeking AlphaMar 5

Cerecor secures $8M capital raise

Cerecor (NASDAQ:CERC) inks an agreement with H.C. Wainwright for the minimum purchase of ~1.5M shares of common stock that it will sell to public investors at $5.50 per share.

158
MarketBeatMar 5

Stock Price, News, & Analysis for Cerecor

Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation. It also offers Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension; and Flexichamber. The company is develop...

8
Simply Wall StFeb 22

The Cerecor Share Price Has Gained 67% And Shareholders Are Hoping For More

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! By buying an index fund, you can roughly match the market return with ease. But if you pick the right individual stocks, you could make more than that. Just take a look at Cerecor Inc. (NASDAQ:CERC), which is up 67%, over three years, soundly beating the market return of 54%. On the other hand, the returns haven’t been quite so good recently, with shareholders up just 28%. Check out our latest ...

48

Earnings

-$0.19
-$0.13
-$0.06
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
-$0.18 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.